Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer

Commentary
Video

Nurse Practitioner Kathleen Lutz talks about the efficacy of chemotherapy in patients with endometrial cancer, and how she discusses the chance of disease recurrence with patients.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Gynecologic Cancers
Related Content
Image of patients of different ages in a waiting room

Risk Factors Determine Symptom Burden Profiles by Age Group

Bridget Hoyt
April 18th 2025
Article

Emetogenic chemotherapy regimens and back pain were associated with higher symptom burden in older, vs younger, patients with cancer.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Photo of a woman with her hand on her forehead in stress

Opinion: Crowdfunding Falls Short in Gynecologic Cancer

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
Published: April 14th 2025 | Updated: April 16th 2025
Article

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing emotional support.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Line illustration of the female reproductive system with a tumor in the uterine lining

Opinion: Social Support is Key to Endometrial Cancer Recovery

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
April 6th 2025
Article

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving communication with the patient.

Rendering of endometrial cancer cells

Biocartis Launches qPCR POLE/POLD1 Mutational Assay

Bridget Hoyt
April 4th 2025
Article

Biocartis announced the launch of its real-time quantitative polymerase chain reaction assay to detect POLE and POLD1 mutations in endometrial cancer.